189 related articles for article (PubMed ID: 38186577)
1. NAD+ associated genes as potential biomarkers for predicting the prognosis of gastric cancer.
Sun X; Wen H; Li F; Bukhari I; Ren F; Xue X; Zheng P; Mi Y
Oncol Res; 2023; 32(2):283-296. PubMed ID: 38186577
[TBL] [Abstract][Full Text] [Related]
2. A prognostic NAD+ metabolism-related gene signature for predicting response to immune checkpoint inhibitor in glioma.
Jiang C; Zhou Y; Yan L; Zheng J; Wang X; Li J; Jiang X
Front Oncol; 2023; 13():1051641. PubMed ID: 36845744
[TBL] [Abstract][Full Text] [Related]
3. Integrating RNA-seq and scRNA-seq to explore the biological significance of NAD + metabolism-related genes in the initial diagnosis and relapse of childhood B-cell acute lymphoblastic leukemia.
Lin C; Xu JQ; Zhong GC; Chen H; Xue HM; Yang M; Chen C
Front Immunol; 2022; 13():1043111. PubMed ID: 36439178
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of nicotinamide adenine dinucleotide (NAD
Cai L; Ke C; Lin Z; Huang Y; Wang A; Wang S; Chen C; Zhong C; Fu L; Hu P; Chai J; Zhang H; Zhang B
J Gastrointest Oncol; 2022 Dec; 13(6):2845-2862. PubMed ID: 36636067
[TBL] [Abstract][Full Text] [Related]
5. Targeting NAD metabolism regulates extracellular adenosine levels to improve the cytotoxicity of CD8+ effector T cells in the tumor microenvironment of gastric cancer.
Liu HY; Wang FH; Liang JM; Xiang YY; Liu SH; Zhang SW; Zhu CM; He YL; Zhang CH
J Cancer Res Clin Oncol; 2023 Jul; 149(7):2743-2756. PubMed ID: 35776198
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.
Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS
BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183
[TBL] [Abstract][Full Text] [Related]
7. N6-methyladenosine-related lncRNAs identified as potential biomarkers for predicting the overall survival of Asian gastric cancer patients.
Xu S; Chen W; Wang Y; Zhang Y; Xia R; Shen J; Gong X; Liang Y; Xu J; Tang H; Zhao T; Zhang Y; Chen T; Wang C
BMC Cancer; 2022 Jul; 22(1):721. PubMed ID: 35778697
[TBL] [Abstract][Full Text] [Related]
8. A novel copper-induced cell death-related lncRNA prognostic signature associated with immune infiltration and clinical value in gastric cancer.
Wang L; Xiao K; Dong Z; Meng T; Cheng X; Xu Y
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10543-10559. PubMed ID: 37291405
[TBL] [Abstract][Full Text] [Related]
9. Development of prognostic indicator based on NAD+ metabolism related genes in glioma.
Chen X; Wu W; Wang Y; Zhang B; Zhou H; Xiang J; Li X; Yu H; Bai X; Xie W; Lian M; Wang M; Wang J
Front Surg; 2023; 10():1071259. PubMed ID: 36778644
[TBL] [Abstract][Full Text] [Related]
10. A new risk model based on a 11-m
Lei L; Li N; Yuan P; Liu D
BMC Cancer; 2022 Apr; 22(1):365. PubMed ID: 35382776
[TBL] [Abstract][Full Text] [Related]
11. Identification of a novel m6A-related lncRNA pair signature for predicting the prognosis of gastric cancer patients.
Wang JM; Li X; Yang P; Geng WB; Wang XY
BMC Gastroenterol; 2022 Feb; 22(1):76. PubMed ID: 35189810
[TBL] [Abstract][Full Text] [Related]
12. Prognosis analysis and validation of lipid metabolism-associated lncRNAs and tumor immune microenvironment in bladder cancer.
Tan Z; Fu S; Zuo J; Wang J; Wang H
Aging (Albany NY); 2023 Aug; 15(16):8384-8407. PubMed ID: 37632832
[TBL] [Abstract][Full Text] [Related]
13. NAD
Ye B; Pei Y; Wang L; Meng D; Zhang Y; Zou S; Li H; Liu J; Xie Z; Tian C; Jiang Y; Qiao Y; Gao X; Zhang Y; Ma N
J Cell Biochem; 2024 Mar; 125(3):e30522. PubMed ID: 38224175
[TBL] [Abstract][Full Text] [Related]
14. Identification of NAD
Lin L; Chen L; Xie Z; Chen J; Li L; Lin A
Front Genet; 2022; 13():905238. PubMed ID: 35783253
[No Abstract] [Full Text] [Related]
15. Integrated Analysis of lncRNA-Associated ceRNA Network Identifies Two lncRNA Signatures as a Prognostic Biomarker in Gastric Cancer.
Zhang S; Li S; Guo JL; Li N; Zhang CN; Liu J
Dis Markers; 2021; 2021():8886897. PubMed ID: 34603561
[TBL] [Abstract][Full Text] [Related]
16. Analysis and prognostic significance of tumour immune infiltrates and immune microenvironment of m6A-related lncRNAs in patients with gastric cancer.
Huang J; Song J; Li X; Liu S; Huang W; Shen Z; Cheng Y; Kou S; Gao Z; Tian Y; Hu J
BMC Med Genomics; 2022 Jul; 15(1):164. PubMed ID: 35879790
[TBL] [Abstract][Full Text] [Related]
17. Identification of functional lncRNAs in gastric cancer by integrative analysis of GEO and TCGA data.
Zhang X; Zhang W; Jiang Y; Liu K; Ran L; Song F
J Cell Biochem; 2019 Oct; 120(10):17898-17911. PubMed ID: 31135068
[TBL] [Abstract][Full Text] [Related]
18. [m
Chen S; Dong R; Li Y; Wu H; Liu M
Nan Fang Yi Ke Da Xue Xue Bao; 2022 May; 42(5):681-689. PubMed ID: 35673911
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNAs as potential biomarkers in gastric cancer: Opportunities and challenges.
Yang Z; Guo X; Li G; Shi Y; Li L
Cancer Lett; 2016 Feb; 371(1):62-70. PubMed ID: 26577810
[TBL] [Abstract][Full Text] [Related]
20. Prognosis Risk Model Based on Pyroptosis-Related lncRNAs for Gastric Cancer.
Jiang M; Fang C; Ma Y
Biomolecules; 2023 Mar; 13(3):. PubMed ID: 36979404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]